NQO1 Antibody (YA261)
(Synonyms: DIA4, NMOR1, NQO1, NAD(P)H dehydrogenase [quinone] 1, Azoreductase, DT-diaphorase, Menadione reductase, NAD(P)H:quinone oxidoreductase 1, Phylloquinone reductase, Quinone reductase 1, DTD, QR1)Based on 2 publication(s) in Google Scholar
NQO1 Antibody (YA261) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NQO1.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, ICC/IF, IP, FC
-
Reactivity :
Human, Mouse
-
Formulation:
Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.
-
Conjugation:
Non-conjugated
Publications Citing Use of MedChemExpress (MCE) NQO1 Antibody (YA261)
More
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
IP
IP: Immunoprecipitation
|
|---|---|---|---|---|
| Dilution Ratio | 1:1000-1:5000 | 1:50-1:200 | 1:50-1:100 | Use at an assay dependent concentration. |
Product Details
NQO1 Antibody (YA261) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NQO1.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse
-
Observed Molecular WeightObserved band size: 31 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 31 kDa
Synthetic peptide corresponding to Human NQO1.AA range:1-49.
Endogenous
Protein A affinity purified.
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Cytotechnology
Dietary Zinc activates the Nrf2 signaling pathway to inhibit pyroptosis and attenuate the lung inflammatory response in COPD. [Abstract]2025 Apr;77(2):62. PMID: 39980839
Verification Images
-
Immunocytochemistry analysis of HepG2 cells labeling NQO1 with NQO1 Antibody (HY-P80251) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with NQO1 Antibody (HY-P0251) at 1/50 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
-
Immunocytochemistry analysis of Hela cells labeling NQO1 with NQO1 Antibody (HY-P80251) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with NQO1 Antibody (HY-P80251)at 1/50 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002,Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
-
Flow cytometric analysis of 1X10^6 MCF-7 cells labeling NQO1 Antibody (YA261) (HY-P80251, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/50 dilution for an hour at 4℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti- Rabbit IgG H&L (HY-P8002) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Rabbit IgG Isotype Control (HY-P80879, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Background
-
Function
NQO1 (NAD (P) H:quinone oxidoreductase 1) is a cytosolic flavoprotein that catalyzes the obligate two-electron reduction of endogenous and exogenous quinones to hydroquinones, thereby limiting semiquinone formation, redox cycling, and reactive oxygen species generation[1][2]. Through this catalytic activity, NQO1 functions as a major cellular defense enzyme that supports redox homeostasis and protects cells from oxidative and electrophilic stress[1][3]. Mechanistically, NQO1 is a prominent downstream target of the Keap1-Nrf2-ARE signaling pathway, and its transcription is strongly induced during oxidative stress and xenobiotic exposure, linking environmental stress responses to cytoprotective gene expression programs[3][4]. In disease contexts, NQO1 is frequently overexpressed in multiple solid tumors, including lung, breast, liver, colon, and pancreatic cancers, where elevated expression is associated with adaptation to oxidative stress and altered responses to therapeutic agents[3][5][6]. Compared with the related isoform NQO2, NQO1 is the predominant stress-inducible quinone reductase and utilizes NADH or NADPH as reducing cofactors, whereas NQO2 exhibits distinct cofactor preferences and biological regulation, supporting nonredundant cellular functions[7][6]. For experimental applications, NQO1 is widely used as a model enzyme for investigating redox regulation, quinone metabolism, and cytoprotective signaling pathways, while the inhibitor dicoumarol remains a commonly employed pharmacological tool for probing NQO1-dependent biological mechanisms[2][6].
-
Subcellular Localization
Cytoplasm, cytosol
-
Expression
Induction:By dioxin (PubMed:1657151) . By oxidative stress (PubMed:21636573) -
Subunit
Homodimer (PubMed:10543876, PubMed:10706635, PubMed:11587640, PubMed:11735396, PubMed:16700548, PubMed:28291250). Interacts with PDLIM4 isoform 2; this interaction stabilizes PDLIM4 isoform 2 in response to oxidative stress and protects it from ubiquitin-independent degradation by the core 20S proteasome (PubMed:21636573). Interacts with TP73 (via SAM domain); this interaction is NADH-dependent, stabilizes TP73 in response to oxidative stress and protects it from ubiquitin-independent degradation by the 20S proteasome (PubMed:15687255, PubMed:28291250). Interacts with TP53; this interaction is NADH-dependent, stabilizes TP53 in response to oxidative stress and protects it from ubiquitin-independent degradation by the 20S proteasome (PubMed:15687255)
-
SwissProt ID
-
Synonyms
DIA4, NMOR1, NQO1, NAD(P)H dehydrogenase [quinone] 1, Azoreductase, DT-diaphorase, Menadione reductase, NAD(P)H:quinone oxidoreductase 1, Phylloquinone reductase, Quinone reductase 1, DTD, QR1
-
Research Field
Signal Transduction
Documentation
-
Data Sheet (262 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
User Guide for Antibodies (1077 KB)
[1]. Dinkova-Kostova AT, et al. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010 Sep 1;501(1):116-23. [Content Brief]
[2]. Bianchet MA, et al. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO). Methods Enzymol. 2004;382:144-74. [Content Brief]
[3]. Lee WS, et al. Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases. Life (Basel). 2021 Nov 26;11(12):1301. [Content Brief]
[4]. Ross D, et al. Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch. Front Physiol. 2017 Aug 24;8:595. [Content Brief]
[5]. Yang Y, et al. Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res. 2014 Feb 5;33(1):14. [Content Brief]
[6]. Pey AL, et al. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Biosci Rep. 2019 Jan 3;39(1):BSR20180459. [Content Brief]
[7]. Jaiswal AK, et al. Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphisms. Pharmacogenetics. 1999 Jun;9(3):413-8. [Content Brief]